---
title: "At the end of the first quarter, the social security fund held multiple innovative drug concept stocks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242520090.md"
description: "Multiple innovative drug concept stocks have gained favor from the social security fund. Statistics show that in this year's first quarterly report, a total of 15 stocks were heavily held by the social security fund, with a combined market value of holdings reaching 4.102 billion yuan, of which 6 stocks were newly added in the first quarter. Wolwo Pharma, Tigermed, and Zelgen ranked highest in market value held by the social security fund, at 555 million yuan, 488 million yuan, and 475 million yuan, respectively"
datetime: "2025-05-30T06:39:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242520090.md)
  - [en](https://longbridge.com/en/news/242520090.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242520090.md)
---

# At the end of the first quarter, the social security fund held multiple innovative drug concept stocks

Multiple innovative drug concept stocks have gained favor from the social security fund. Statistics show that in this year's first quarter report, a total of 15 stocks were heavily held by the social security fund, with a total holding market value reaching 4.102 billion yuan, of which 6 stocks were newly added to the heavy holdings in the first quarter. Wolwo Pharma, Tigermed, and Zelgen ranked highest in market value held by the social security fund, at 555 million yuan, 488 million yuan, and 475 million yuan, respectively

### Related Stocks

- [688266.CN](https://longbridge.com/en/quote/688266.CN.md)
- [300357.CN](https://longbridge.com/en/quote/300357.CN.md)
- [300347.CN](https://longbridge.com/en/quote/300347.CN.md)
- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)

## Related News & Research

- [BUZZ-Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO](https://longbridge.com/en/news/294533308.md)
- [Mexedia raises EUR 500,000 via Rockbridge share subscription at EUR 2.5 each](https://longbridge.com/en/news/293916940.md)
- [Xianghe Capital-backed Valhalla Tech completes multi-round funding totaling nearly USD 50 million](https://longbridge.com/en/news/294370235.md)
- [Hofseth BioCare says ProGo trial lifts GLP-1 markers, lean muscle mass in overweight adults](https://longbridge.com/en/news/293889907.md)
- [03:00 ETSe ha demostrado que el extracto de algas marinas alivia los síntomas de la próstata](https://longbridge.com/en/news/293891675.md)